HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Total synthesis of englerin A.

Abstract
Total synthesis of englerin A, a recently reported sesquiterpenoid exhibiting potent and selective growth inhibition against renal cancer cell lines, has been accomplished. The successful strategy featured a [5 + 2] cycloaddition reaction to cast the seven-membered oxabicyclic key intermediate in both racemic and optically active forms. Synthetic (+/-)-englerin A, (+/-)-englerin B, (+/-)-englerin B acetate, a hydroxy acetate, a tert-butyldimethylsilyl ether, and hydrogenated (+/-)-englerin A (31) were tested for their cytotoxicity against a selected panel of cancer cell lines, and the results are path-pointing to more focused structure-activity relationship studies.
AuthorsK C Nicolaou, Qiang Kang, Sin Yee Ng, David Y-K Chen
JournalJournal of the American Chemical Society (J Am Chem Soc) Vol. 132 Issue 23 Pg. 8219-22 (Jun 16 2010) ISSN: 1520-5126 [Electronic] United States
PMID20496885 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Antineoplastic Agents
  • Esters
  • Sesquiterpenes, Guaiane
  • englerin A
  • englerin B
Topics
  • Acetates (chemistry)
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Esters (chemistry)
  • Humans
  • Inhibitory Concentration 50
  • Kidney Neoplasms (pathology)
  • Sesquiterpenes, Guaiane (chemical synthesis, chemistry, pharmacology)
  • Stereoisomerism

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: